While Pfizer fell 3%, many investors were encouraged by the Food & Drug Administration’s full approval of its COVID-19 vaccine. Source
While Pfizer fell 3%, many investors were encouraged by the Food & Drug Administration’s full approval of its COVID-19 vaccine. Source